{"id":"NCT00984126","sponsor":"Novo Nordisk A/S","briefTitle":"Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015","officialTitle":"Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-26","primaryCompletion":"2016-06-28","completion":"2016-06-29","firstPosted":"2009-09-25","resultsPosted":"2017-07-27","lastUpdate":"2017-07-27"},"enrollment":214,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa","otherNames":[]},{"type":"DRUG","name":"turoctocog alfa","otherNames":[]}],"arms":[{"label":"Turoctocog alfa","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe, Japan, Oceania, North America and South America.\n\nThe aim of the trial is to investigate the safety and efficacy of turoctocog alfa (N8) in Haemophilia A patients.\n\nThe trial is an extension to trials NN7008-3543 (start: March 2009, stop: September 2011) and NN7008-3545 (start: May 2010, stop: November 2011) and the pharmacokinetic trials NN7008-3600 (start: November 2010, stop: October 2011), NN7008-3893 (start: June 2011, stop: September 2011) and NN7008-4015 (start: August 2012, stop: March 2013).","primaryOutcome":{"measure":"Frequency of Development of FVIII Inhibitors (Greater Than or Equal to 0.6 Bethesda Units (BU)/mL)","timeFrame":"After 90 months","effectByArm":[{"arm":"Small Children (0 - <6 Years)","deltaMin":0,"sd":null},{"arm":"Older Children (6 - <12 Years)","deltaMin":0,"sd":null},{"arm":"Adolescents (12 - <18 Years)","deltaMin":0,"sd":null},{"arm":"Adults (≥18 Years)","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003","p":null}]},"eligibility":{"minAge":"6 Months","sex":"MALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":57,"countries":["United States","Brazil","Croatia","Germany","Israel","Italy","Japan","Latvia","Lithuania","Malaysia","North Macedonia","Poland","Puerto Rico","Russia","Serbia","Spain","Switzerland","Taiwan","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["26058730","27291066"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":27},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Arthralgia","Cough"]}}